11 London
11 London has unveiled a new creative director in the form of Steve Broadhurst (pictured above), who joins the agency brining more than 20 years experience in healthcare and not-for-profit campaigns.
Broadhurst was previously Executive Creative Director & Managing Partner at GHG London, where he built up the creative department as well as winning and developing clients for more than six years. He was part of the WPP team that won the global account for Xarelto, tasked with re- imagining Bayer’s biggest selling drug.
He said: “Having worked across health and not for profit, it is hugely exciting to join 11, which puts these issues at the heart of everything they do. Experience tells me that wellbeing and digital innovation is critical to success, so you can evidence campaign impact, while engaging and involving patients. 11 have proven success in both these fields.”
Broadhurst’s healthcare experience in build on work with multiple pharma companies, including Glaxo Smith Kline, Pfizer and AstraZeneca.
11 London’s managing director Matt Hunt, who has worked with Broadhurst at GHG on numerous campaigns, said: “Steve is the person we’ve been looking for, and when he became free we didn’t hesitate in inviting him to join 11. He’s unique in being so well versed in both health and humanity, and having won many creative awards in both.
“He’s created fantastic and highly emotive film and TV content as well
as building some of the biggest global health brands in recent history. I really couldn’t think of a better creative head.”
MSL
MSL has strengthened its healthcare team, appointing Katy Compton-Bishop (pictured below) as its senior director.
Compton-Bishop has over 20 years’ healthcare communications experience and most recently held the position of head of healthcare at Ruder Finn.
With expertise in strategic communications, multi-stakeholder engagement and patient activation, she has supported pharma brands across multiple channels and geographies and been responsible for leading large scale campaigns for clients such as UCB, GSK and Novartis.
She said: “I am delighted to be joining the healthcare team at MSL. The breadth of expertise across the agency, combined with the ability to truly deliver integrated communications campaigns, makes MSL ideally placed to address a diverse and evolving communications landscape. I look forward to contributing to the company’s continued success.”
ramarketing
Pharma and life sciences marketing agency ramarketing has appointed Emma Banks (pictured above) as its new managing director, a role in which Banks will oversee the company’s growth.
Formerly chief executive officer of life sciences software group Datatrial, Banks will take over the operational reins from remarketing’s founder Raman Sehgal, who has transferred to Boston to run the company’s first US office.
The new office in Cambridge, Massachusetts, will give ramarketing a presence in the growing pharma and biotech hub and a foothold in the US market, allowing it to locally service its US clients and assist European clients with their US growth strategies.
Founder and global president, Raman Sehgal, said: “Emma is a well-known industry figure with a wealth of senior level experience. Her experience of growing a technology company into a highly successful international operation makes her an ideal candidate for the role.
“Emma’s insight into the global life sciences sector means she fully understands the value of opening up in the US market, and how it will help to accelerate our development. Her warm and energetic leadership style and solid moral compass make her a great fit for our company culture.
“Emma will manage our strategic European growth plans, ensuring we continue to deliver world class service to our clients. Bringing her on board to run day-to-day operations enables me to focus on building our North American business and also frees me up to be more hands-on supporting clients’ businesses.”